Drug Shortage Report for RAN-MONTELUKAST

Last updated on 2019-11-08 History
Report ID 97784
Drug Identification Number 02389517
Brand name RAN-MONTELUKAST
Common or Proper name RAN-MONTELUKAST
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Active Ingredient(s) MONTELUKAST
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-25
Estimated end date 2019-11-15
Actual end date 2019-11-08
Shortage status Resolved
Updated date 2019-11-08
Company comments
Health Canada comments
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-11-08 French Compare
v3 2019-11-08 English Compare
v2 2019-11-01 French Compare
v1 2019-11-01 English Compare